Suppr超能文献

由不同的贝氏柯克斯体Ⅰ相菌株制备的颗粒性疫苗和可溶性疫苗的免疫原性及保护能力。

Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.

作者信息

Kazár J, Gajdosová E, Kovácová E, Valková D

机构信息

Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic.

出版信息

Acta Virol. 1995 Dec;39(5-6):243-9.

PMID:8722292
Abstract

BALB/c mice immunized intraperitoneally (ip) with killed purified Coxiella burnetii phase I corpuscular vaccines or trichloroacetic acid (TCA) extracts from phase I corpuscles (soluble vaccines) were protected against ip challenge with both homologous and heterologous C. burnetii phase I strains. Though the degree of protection, namely the inhibition of C. burnetii multiplication in the mouse spleen slightly varied, in general, corpuscular vaccines provided better protection than soluble ones. Cross-protection was accompanied by comparable levels of cell-mediated immune response as evaluated by lymphocyte transformation test (LTT). However, higher stimulation indices of LTT were obtained with homologous than with heterologous strains. The values of antibody response as determined by enzyme-linked immunosorbent assay (ELISA) were higher with homologous strains too. On average, both antibody-inducing and antibody-binding capabilities of the strains Priscilla and S were lower than those of the Nine Mile and Luga strains, except for values obtained with the antigens from homologous strains.

摘要

用灭活的纯化贝氏柯克斯体I相微粒疫苗或I相微粒的三氯乙酸(TCA)提取物(可溶性疫苗)经腹腔内(ip)免疫的BALB/c小鼠,对同源和异源贝氏柯克斯体I相菌株的腹腔内攻击具有抵抗力。尽管保护程度,即小鼠脾脏中贝氏柯克斯体增殖的抑制略有不同,但总体而言,微粒疫苗比可溶性疫苗提供更好的保护。通过淋巴细胞转化试验(LTT)评估,交叉保护伴随着相当水平的细胞介导免疫反应。然而,同源菌株的LTT刺激指数高于异源菌株。通过酶联免疫吸附测定(ELISA)测定的抗体反应值,同源菌株也更高。平均而言,除了同源菌株抗原获得的值外,普里西拉和S菌株的抗体诱导和抗体结合能力均低于九英里和卢加菌株。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验